<DOC>
	<DOCNO>NCT01359956</DOCNO>
	<brief_summary>This study evaluate two chemotherapy regimen without addition interferon patient advance recurrent melanoma .</brief_summary>
	<brief_title>Fotemustine Dacarbazine Versus Dacarbazine +/- Alpha Interferon Advanced Malignant Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Fotemustine</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Histologically confirm diagnosis malignant melanoma advance stage recurrent surgery , amenable surgery local therapy . Presence measurable disease Age &gt; = 18 year &lt; = 75 year Performance status ( ECOG ) 0 2 ( Appendix 2 ) Life expectancy 続 3 month Adequate bone marrow function ( ANC 続 2,000/mmc ; PTL 続 100,000/mmc ; Hb 続 10 gr/dl ) , normal liver renal function ( bilirubin &lt; 1.25 x N , creatinine &lt; 1.25 x N , SGOT , SGPT &lt; 3 time upper normal limit test laboratory . Written , inform consent prior study specific procedure , understand patient right withdraw study time , without prejudice . Prior surgery &gt; 3 week initiate . If palliative radiation need , case non target lesion , must give prior initiate chemotherapy . If palliative radiation require study patient permanently discontinue treatment . Adequate contraceptive measure study participation sexually active patient child bear potential must implement . Previous concurrent malignancy sit exception surgically cure carcinoma insite cervix basal squamous cell carcinoma skin . Prior chemoimmunotherapy ( previous adjuvant immunotherapy allow ) Known HIV disease . Concurrent treatment experimental drug . Concurrent chemotherapy , immunotherapy , hormonal therapy ( exclude contraceptive replacement steroid ) , radiation therapy Pregnant lactating female Previous concurrent malignancy sit exception surgically cure carcinoma insite cervix basal squamous cell carcinoma skin . Prior chemoimmunotherapy ( previous adjuvant immunotherapy allow ) Known HIV disease . Concurrent treatment experimental drug . Concurrent chemotherapy , immunotherapy , hormonal therapy ( exclude contraceptive replacement steroid ) , radiation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>